German Electron Synchrotron

The German Electron Synchrotron (Deutsches Elektronen-Synchrotron – DESY) is one of the world’s leading laboratories for photon science and particle physics. As a member of the Helmholtz Association in Germany, DESY is a non-profit research organization funded by public funds from the government and the states. The research carried out at DESY is extremely diverse. Researchers are looking for the tiniest building blocks of matter that make up our world, developing innovative high-tech materials and searching for new mechanisms of action for future medications. DESY has a long-standing experience in the design and operation of accelerators and detectors for high energy physics and synchrotron radiation research. At the time being, DESY operates the most brilliant synchrotron radiation source world-wide and two Free Electron Lasers.

Role of institution in the project

DESY has considerable experience in managing data in distributed environments. DESY will contribute to task 4.2 in WP4 in providing data transfers as a core service for the central hub.

Patrick Fuhrmann

Patrick Fuhrmann (male) is a Senior Scientist and leads the area "Research and Innovation in Scientific Computing" at DESY IT. Patrick holds a PhD in Physics from RWTH Aachen University and has been working in the area of Big Data and storage access for more than 15 years. He led the international dCache collaboration that provides storage solutions for over 70 scientific labs worldwide. He is involved in a number of H2020 projects and coordinated the ExPaNDS,eu project that promoted FAIR data use for European Photon and Neutron facilities. He also holds a professorship at HTW Berlin.

Thomas Beermann

Thomas Beermann works as a software engineer in the "Research and Innovation in Scientific Computing" group at DESY IT. Thomas is mainly working on the Helmholtz Cloud Portal, a catalogue of shared IT services for the Helmholtz Association. He has more than 10 year of experience in area of grid computing and distributed data management. Before joining DESY in 2021, he was working in the group responsible for the data management in the ATLAS experiment at CERN. There he was one of the core developers of Rucio, a distributed data management solution that allows scientific collaborations to manage large volumes of data. Thomas holds a PhD in Computer Science from the University of Wuppertal.

Join the EUCAIM Consortium

Open Call for New Beneficiaries

We’re inviting new partners to enhance our pan-European infrastructure for cancer images and artificial intelligence.

Whether you’re a data holder with valuable cancer images or an innovator developing AI tools for precision medicine, this is your chance to contribute to a groundbreaking project.

Apply by 10 June 2024!

Open Call Webinar

We recently hosted a webinar with more details for prospective applicants to the open call. A recording is available.

Our open Call for new collaborators
launches in April 2024

Opportunities for data holders & AI developers to contribute await! Let‘s join forces to enhance cancer diagnosis and treatment

Be the first to know and apply!

March 14, 10:00-11:30 aM CET



Explore the potential for AI-driven cancer care advancements!
Learn how to access and utilize our federated cancer image repository. The webinar is for AI Innovators & Data Providers interested in the platform and will feature an introduction to EUCAIM & Cancer Image Europe and a demonstration of data exploration & access.

Survey Invitation

Join Leading Experts In Shaping AI In Cancer

EUCAIM is looking for your feedback! We have recently published a Stakeholder Survey in order to reach out to potential end-users and stakeholders. We believe that your insights could significantly contribute to understanding the expectations of potential users and identifying the essential aspects that stakeholders find crucial for future engagement and collaboration with the platform.

Therefore, we would like to invite you to participate in the Stakeholder Survey about the Cancer Image Europe platform.

Completing the survey will take approximately 10 minutes. Your participation is crucial to the success of this project, and we deeply appreciate your expertise in shaping the future of cancer imaging and treatment.